Hydroxychloroquine sulfate

硫酸羟氯喹

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameHydroxychloroquine sulfate
Drug Alias Name羟基氯喹盐酸盐Hydroxychloroquine hydrosulfatehidroxicloroquina羟氯喹硫酸氢盐hydroxychloroquinum +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsBone metastasesCoronavirus Disease 2019 (COVID-19)Skin Melanoma +[43] 
Global Approved IndicationsLupus Erythematosus, SystemicLupus Erythematosus, DiscoidLupus Erythematosus, Cutaneous +[5] 
Approved Indications in ChinaLupus Erythematosus, SystemicArthritis, Rheumatoid
Original Approved Country/TerritoryUnited States
Original Approved Date1955/04/18
Country/TerritoryBelgiumCanadaUnited States +[23] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesKadmon Corporation Llc
China Registration ClassN/A

Develop Information

Active CompaniesUtah State UniversitySanofiUniversity Of Calgary +[8] 
Inactive CompaniesSaw Swee Hock School Of Public HealthDana-Farber Cancer InstituteScandibio Therapeutics Ab +[65] 
Active IndicationsCoronavirus Disease 2019 (COVID-19)ParturitionLupus Erythematosus, Systemic +[12] 
Inactive IndicationsBone metastasesSkin MelanomaSolid tumours +[31] 

Other Information

ATC CodeP01BA02
Related LinksWikipediaDrugBankKEGG